CA
NGVT icon

Claris Advisors’s Ingevity NGVT Stock Holding History

Claris Advisors’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$39 – 769
2024
Q3 		$39 Buy
+1
New +$40 ﹤0.01% 1207

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Claris Advisors's NGVT Position: Q4 2024 in Review

Claris Advisors sold out of Ingevity (NGVT) in Q4 2024, closing a stake of 1 share — an estimated $39 sold.

Claris Advisors first reported a position in NGVT in Q3 2024 and held it in 1 quarter. The position peaked at $39 in Q3 2024. 257 funds tracked by Wall St. Rank hold NGVT as of Q4 2024.

  • Claris Advisors reported no remaining Ingevity position as of Q4 2024 after selling out during the quarter.
  • Claris Advisors sold 1 Ingevity share in Q4 2024, an estimated $39.
  • Claris Advisors first reported a position in Ingevity in Q3 2024 and held it in 1 quarter.
  • Claris Advisors's Ingevity position peaked at $39 in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Ingevity as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.